TMEM33 deletion potentiates anti-tumor CD8+ T cell immunity
Matthew P. Jackson, T. Zhao, Gusztav Milotay, Isabela Pedroza‐Pacheco, Yanshu Cai, Claire Willis, Su Myat Phyu, Bruno Beernaert, J. Kwon, Hala Estéphan, Vinnycius Pereira Almeida, Maria Aggelakopoulou, Silvia Panetti, Christian Zierhut, Tim J Elliott, , Eileen E. Parkes
This study shows TMEM33 limits progenitor-exhausted CD8+ T cells, enhances anti-tumor responses, and correlates with improved survival in melanoma patients.
bioRxiv · Jan 2, 2026 · PreprintImmunology